Lite Strategy, Inc. (LITS)

CIK 0001262104 · Healthcare · Biotechnology

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
— FY-2026 8-K (2026-07-30) · 99.1
Latest Q3-2026 8-K (2026-05-13) · 99.1
Q2-2025 8-K (2026-02-17) · 99.1  |  8-K (2025-02-12) · 99.1  |  8-K (2024-11-14) · 99.1
Q1-2025 —
Latest FY-2025 —
Q3-2025 8-K (2025-05-13) · 99.1
Q2-2025 8-K (2026-02-17) · 99.1  |  8-K (2025-02-12) · 99.1  |  8-K (2024-11-14) · 99.1
Q1-2025 —
FY-2024 8-K (2024-09-19) · 99.1
Q3-2024 8-K (2024-05-09) · 99.1
Q2-2024 8-K (2024-02-13) · 99.1
Q1-2024 8-K (2023-11-09) · 99.1
FY-2023
FY-2023 8-K (2023-09-26) · 99.1

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover Page
Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (P)
Consolidated Statements of Operations
Consolidated Statements of Stockholders' Equity
Consolidated Statements of Stockholders' Equity (P)
Consolidated Statements of Cash Flows
Notes
Award Timing Disclosure
—
Balance Sheet Details
Commitments and Contingencies
Cybersecurity Risk Management, Strategy and Governance
—
Derivatives
—
Description of Business and Basis of Presentation
Digital Assets
—
Disposition of A Non-financial Asset
Disposition of A Nonfinancial Asset
—
Employee Termination Benefits
—
Fair Value Measurements
Income Taxes
—
Insider Trading Arrangements
Insider Trading Policies and Procedures
—
Leases
License Agreements
Master Loan Agreement
—
One-time Employee Termination Benefits
One-time Termination Benefits
—
Other License Agreements
Pay Vs Performance Disclosure
Related Party Transactions
—
Segment Information
Share-based Compensation
Stockholders' Equity
Subsequent Events
Summary of Significant Accounting Policies
The Company and Summary of Significant Accounting Policies
—
Warrants
—